DCGI Moves To Check Import Of Fake Cosmetics

New Delhi: The Drugs Controller General of India (DCGI) has asked importers of cosmetics to provide information on consignments coming into the country, as it looks to prevent sale of unregulated and fake products, according to people aware of the development. The regulator has sought information on the number of consignments, their bills, the quantity imported, and cost of imported cosmetics, among other details.

The importers ET spoke with confirmed receiving the DCGI’s notice. Earlier, the DCGI had issued show-cause notices to ecommerce portals for the selling and distribution of spurious, adulterated cosmetics and cosmetics manufactured without valid licence in contravention of the Drugs and Cosmetics Act, 1940.

“The Cosmetics Rules, 2020 have been notified on 15.12.2020 by the government of lndia under the Drugs and Cosmetics Act, 1940 (23 of 1940),” it said in the notice dated February 23.

“This office has granted import registration number (lRN) under Form Cos-4A for cosmetics, which are already registered under Rule 13 for import and sale into india.” In the notice, seen by ET, the regulator said that as per the requirements of conditions of IRN under Form Cos 4A, the importer shall provide the statement of details of cosmetics imported annually to the Central Licensing Authority.

However, it added that the details of cosmetics imported annually by importers are not being provided to their office.

The DCGI has hence asked for details like the annual statement of details of cosmetics imported in india from the date of grant of IRN under Cos-4A to their office including details such as number of consignments, bill of entries of each consignment, imported quantity in each consignment, total cost of imported cosmetics in each consignment, warehouse details where those are stored for further distribution and sale among other details.

Earlier, raids were carried out which revealed the extent of illegal cosmetics in the market.

The seized goods included mesenchymal stem cell-based creams, oral glutathione and placenta and glutathione injections, hyaluronic acid injections, botulinum toxin injections, hair serum, peels made with various other ingredients, collagen pyruvate, biotin hydroxin, caffeine 100%, anti-hair loss solutions, skin peel exfoliators, etc.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?